ArticleBMC public health2025
Construction of a machine learning-based risk prediction model for depression in middle-aged and elderly patients with cardiovascular metabolic diseases in China: a longitudinal study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Ultrasound-assisted extraction of Allium macrostemon Bunge polysaccharides: optimization of extraction process, structural characterization and immunomodulatory effects.Ultrasonics sonochemistry · 2026Article
- Article
- Development and Validation of a Machine Learning-Based Prediction Model for Cardiovascular Disease in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026Article
- Machine learning prediction models for visual impairment in Chinese adults aged ≥ 45 years with cardiovascular metabolic diseases: a population-based study using CHARLS.BMC ophthalmology · 2025Article
- Prediction model for depression risk in middle-aged and elderly patients with metabolic syndrome: a nomogram and interpretable machine learning approach based on CHARLS.BMC psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe incidence of cardiovascular metabolic diseases (CMD) continues to rise among middle-aged and elderly populations, affecting not only physical health but also significantly increasing the risk of depression. This study aims to construct a machine learning model to predict the risk of depression in middle-aged and elderly patients with CMD and to identssify key risk factors.
methodsBased on data from the China Health and Retirement Longitudinal Study (CHARLS) from 2018 to 2020, 4,477 patients aged 45 and above were included. LASSO regression was used to screen for risk factors, and three machine learning algorithms-logistic regression (LR), random forest (RF), and XGBoost-were employed to build predictive models. The performance of the models was evaluated using ROC curves, calibration curves, and decision curves.
resultsThe study found several risk factors significantly associated with depression, including disability status, pain, retirement status, number of chronic diseases, education level, age, gender, place of residence, life satisfaction, optimism about the future, and self-rated health status. The incidence of depression was significantly higher among women (56%), rural residents (64%), individuals with disabilities, non-retirees (85%), and those with chronic illnesses (73%). The LR model demonstrated the best predictive performance, with an AUC of 0.69. Key predictive factors included self-rated health, residence, education level, gender, pain, life satisfaction, age, and hope for the future.
conclusionThis study developed a depression risk prediction model based on logistic regression, providing important references for psychological health interventions in middle-aged and elderly patients with CMD. Identifying and intervening in high-risk populations is crucial for improving patients' quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.